Suppr超能文献

乳腺癌治疗后的性生活:医生对当前临床实践的调查。

Sexuality after breast cancer treatment: A physician's survey of current clinical practice.

机构信息

University Hospital Leuven, Herestraat 49, 3000 Leuven, Belgium.

University Hospital Leuven, Herestraat 49, 3000 Leuven, Belgium.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2024 Nov;302:317-324. doi: 10.1016/j.ejogrb.2024.09.020. Epub 2024 Sep 14.

Abstract

BACKGROUND

Side effects of breast cancer treatment (BCT) impact patients' general and sexual wellbeing. Sexuality related complaints are reported by 70% of breast cancer survivors mainly due to the genitourinary syndrome of menopause (GSM). In clinical care, sexual side effects are often un(der)detected because physicians as well as patients experience barriers to discuss sexuality-related issues.

MATERIALS AND METHODS

We composed an online survey ourselves using known definitions about sexuality and menopause and known factors for not discussing sexuality. We used multiple-choice questions with a Likert scale to optimize interpretation of the statements. 64 practitioners completed the survey. With this online survey, we examined physicians' knowledge of -and attitude towards- sexual wellbeing and detection and treatment of GSM in breast cancer survivors (BCS).

RESULTS

Vaginal dryness and dyspareunia were the symptoms most associated with menopause (n = 63/64 (98 %) and n = 56/64 (87 %)) and sexuality (n = 63/64 (98 %) and n = 61/64 (95 %)). These 2 complaints were also the most discussed symptoms of menopause (vaginal dryness n = 51/64 (80 %) and dyspareunia n = 45/64 (70 %)). The main reason to not discuss these issues were absence of reporting GSM (n = 40/64 (62 %)) and absence of a direct cause to discuss GSM (n = 35/64 (55 %). 64 % (n = 41/64) of practitioners don't feel sufficiently educated to discuss and treat GSM. They proposed vaginal estrogens to treat GSM as first or second line respectively in 12 % (n = 8/64) and 46 % (n = 30/64) of symptomatic BCS.

DISCUSSION

Although sexuality related complaints are common in BCS, 64% of all participating physicians feel they are not adequately trained to handle them. More attention towards training of physicians is needed to discuss GSM related complaints also when they are not spontaneously reported by a patient and with clear guidance towards the medical treatment of GSM in BCS.

摘要

背景

乳腺癌治疗(BCT)的副作用会影响患者的整体和性健康。70%的乳腺癌幸存者报告存在与性相关的问题,主要是由于与绝经期相关的泌尿生殖系统综合征(GSM)引起的。在临床护理中,由于医生和患者都存在讨论性相关问题的障碍,因此通常无法(un(der)detect)检测到这些副作用。

材料与方法

我们自行编制了一份在线调查问卷,使用了与性和绝经期相关的已知定义以及与不讨论性相关问题相关的已知因素。我们使用了多项选择题和李克特量表来优化对这些陈述的解释。共有 64 名医生完成了这项调查。通过这项在线调查,我们考察了医生对乳腺癌幸存者(BCS)的性健康和 GSM 的检测和治疗的知识和态度。

结果

阴道干燥和性交困难是与绝经(n=63/64(98%)和 n=56/64(87%))和性(n=63/64(98%)和 n=61/64(95%))最相关的症状。这两种症状也是最常被讨论的与绝经相关的症状(阴道干燥 n=51/64(80%)和性交困难 n=45/64(70%))。不讨论这些问题的主要原因是未报告 GSM(n=40/64(62%))和未直接讨论 GSM 的原因(n=35/64(55%))。64%(n=41/64)的医生认为自己没有接受过充分的教育,无法讨论和治疗 GSM。他们分别建议将阴道雌激素作为治疗 GSM 的一线或二线药物,在有症状的 BCS 中,有 12%(n=8/64)和 46%(n=30/64)的患者选择阴道雌激素。

讨论

尽管与性相关的抱怨在 BCS 中很常见,但 64%的参与医生认为他们没有接受过充分的培训来处理这些问题。需要更多地关注医生的培训,以便在患者没有主动报告且没有明确指导治疗 BCS 中 GSM 的情况下,也能够讨论与 GSM 相关的问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验